Encision INC Form 4 insider transactions

Envision Inc. CEO Robert Fries has acquired a significant number of company shares through a Rule 10b5-1(c) plan, indicating a strong belief in the company's future prospects.

ENCISION INC's CEO and Director, Gregory J. Trudel, was granted options to purchase 10,000 shares of common stock at an exercise price of $0.25, vesting over approximately five years.

Encision Inc. Director Vern D. Kornelsen was granted 10,000 stock options with an exercise price of $0.25, vesting over time.

ENCISION Inc.'s VP of Marketing, Brian J Jackman, was granted options to purchase 10,000 shares of common stock at an exercise price of $0.25.

CMED Partners LLLP, a 10% owner and director, significantly increased its stake in Encision Inc. by purchasing 2 million shares in a private placement.

ENCISION INC CEO Gregory J. Trudel purchased 1,000,000 shares of common stock at $0.10 per share in a private placement.

Encision Inc. Director Robert H. Fries acquired 750,000 shares of common stock through a private placement, increasing his beneficial ownership.

ENCISION's VP of Finance, Brandon Jason Shepard, purchased 1,000,000 shares of common stock at $0.10 per share through a private placement.

Director Vern D. Kornelsen reports acquisition of options to buy 10,000 shares of Encision Inc. common stock.

CEO Gregory J. Trudel reports acquisition of 10,000 shares of Encision Inc. through an option grant.

Brandon Jason Shepard, VP of Finance at Encision Inc., reports the acquisition of stock options.

Director Patrick W. Pace of Encision Inc. acquired 5,000 stock options on November 14, 2024, at an exercise price of $0.42.

Encision Inc. director Vern D. Kornelsen acquired 5,000 stock options at an exercise price of $0.48 on January 16, 2025.

Director Patrick W. Pace of Encision Inc. was granted options to purchase 10,000 shares of common stock.

Peter D. Geary, Director of Strategic Integration at Encision Inc., reports the acquisition and disposal of common stock on December 23, 2024.

Encision Inc.'s CEO, Gregory J. Trudel, engaged in stock transactions on December 23, 2024, acquiring 5,000 shares and disposing of 3,500 shares.

VP of Marketing at Encision Inc., Brian Jackman, reports acquisition and disposal of common stock on December 23, 2024.

Encision Inc.'s Director of Strategic Integration, Peter D. Geary, has been granted an option to purchase 5,000 shares of common stock, according to a recent SEC filing.

Encision Inc.'s CEO, Gregory J. Trudel, has acquired 5,000 stock options, vesting over a period of time, as reported in a recent SEC Form 4 filing.

Brian J. Jackman, VP of Marketing at Encision Inc., was granted options to purchase 5,000 shares of common stock.

Director Vern D. Kornelsen of Encision Inc. was granted 5,000 stock options on November 14, 2024, which vest over a three-year period.

Brandon Jason Shepard, VP of Finance at Encision Inc., reports the acquisition of 25,000 shares via an option grant.

Director Robert H. Fries purchased 35,000 shares of Encision Inc. common stock at $0.368 per share on August 29, 2024.

Encision Inc.'s CEO, Gregory J. Trudel, recently purchased 3,300 shares of the company's common stock at a price of $0.32 per share.

Director Robert H. Fries reports acquisition of 85,000 shares of Encision Inc. through an option grant.

Director Patrick W. Pace acquired 20,000 shares of Encision Inc. through an option grant on April 30, 2024.

Encision Inc. CEO Gregory J. Trudel reports acquisition of 200,000 shares via option grant on April 30, 2024.

VP of Marketing at Encision Inc., Brian J. Jackman, reports acquisition of 40,000 stock options.

Peter D. Geary, Director of Strategic Integration at Encision Inc., reports the acquisition of 20,000 stock options.

Director Patrick W. Pace reports acquisition and disposal of Encision Inc. stock and stock options on April 12, 2024.